AUGMENTATION OF MONOCYTE-MEDIATED IMMUNOTHERAPY OF HUMAN ACUTE MYELOID-LEUKEMIA (AML) WITH A BISPECIFIC ANTIBODY (FAB22X251) TO CD64 (FC-GAMMA-RI) AND CD33 IN A SCID MOUSE MODEL
Citation
Rk. Zhong et al., AUGMENTATION OF MONOCYTE-MEDIATED IMMUNOTHERAPY OF HUMAN ACUTE MYELOID-LEUKEMIA (AML) WITH A BISPECIFIC ANTIBODY (FAB22X251) TO CD64 (FC-GAMMA-RI) AND CD33 IN A SCID MOUSE MODEL, Blood, 88(10), 1996, pp. 860-860
Categorie Soggetti
Hematology
SICI code
0006-4971(1996)88:10<860:AOMIOH>2.0.ZU;2-C